Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Döhner

Showing results (1-10 of 490) with videos related to

Pageof 49
Sort By:
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
The use of molecular markers in selecting therapy for CLLHartmut Döhner
Hematology. American Society of Hematology. Education Program|November 21, 2007
Implication of the molecular characterization of acute myeloid leukemiaHartmut Döhner
Lancet (London, England)|November 28, 2006
Acute myeloid leukaemiaElihu Estey, Hartmut Döhner
The New England Journal of Medicine|August 9, 2002
Campath-1H-induced complete remission of chronic lymphocytic leukemia despite p53 gene mutation and resistance to chemotherapyStephan Stilgenbauer, Hartmut Döhner
Haematologica|July 2, 2008
Molecular characterization of acute myeloid leukemiaKonstanze Döhner, Hartmut Döhner
The New England Journal of Medicine|August 16, 2008
Chromosomal abnormalities in cancerStefan Fröhling, Hartmut Döhner
European Journal of Cancer (Oxford, England : 1990)|June 20, 2006
Cytogenetics and molecular cytogenetics in multiple myelomaPeter Liebisch, Hartmut Döhner
The New England Journal of Medicine|December 3, 2004
Disruption of C/EBPalpha function in acute myeloid leukemiaStefan Fröhling, Hartmut Döhner
Hematology/Oncology Clinics of North America|August 25, 2004
Molecular genetics and its clinical relevanceStephan Stilgenbauer, Hartmut Döhner
Hematology. American Society of Hematology. Education Program|December 14, 2011
Impact of genetic features on treatment decisions in AMLHartmut Döhner, Verena I Gaidzik
Pageof 49

Showing results (1-10 of 490) with videos related to

Sort By:
Pageof 49
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
The use of molecular markers in selecting therapy for CLLHartmut Döhner
Hematology. American Society of Hematology. Education Program|November 21, 2007
Implication of the molecular characterization of acute myeloid leukemiaHartmut Döhner
Lancet (London, England)|November 28, 2006
Acute myeloid leukaemiaElihu Estey, Hartmut Döhner
The New England Journal of Medicine|August 9, 2002
Campath-1H-induced complete remission of chronic lymphocytic leukemia despite p53 gene mutation and resistance to chemotherapyStephan Stilgenbauer, Hartmut Döhner
Haematologica|July 2, 2008
Molecular characterization of acute myeloid leukemiaKonstanze Döhner, Hartmut Döhner
The New England Journal of Medicine|August 16, 2008
Chromosomal abnormalities in cancerStefan Fröhling, Hartmut Döhner
European Journal of Cancer (Oxford, England : 1990)|June 20, 2006
Cytogenetics and molecular cytogenetics in multiple myelomaPeter Liebisch, Hartmut Döhner
The New England Journal of Medicine|December 3, 2004
Disruption of C/EBPalpha function in acute myeloid leukemiaStefan Fröhling, Hartmut Döhner
Hematology/Oncology Clinics of North America|August 25, 2004
Molecular genetics and its clinical relevanceStephan Stilgenbauer, Hartmut Döhner
Hematology. American Society of Hematology. Education Program|December 14, 2011
Impact of genetic features on treatment decisions in AMLHartmut Döhner, Verena I Gaidzik
Pageof 49